Chronic migraine
Chronic migraine is one of the most visible therapeutic indications for botulinum toxin type A, especially through Botox.
Why it is a core indication
Section titled “Why it is a core indication”This indication is strategically important because it shows that botulinum toxin is not limited to movement disorders or aesthetics. It expands the topic graph into neurology and pain management.
Main product relationships
Section titled “Main product relationships”Clinical interpretation
Section titled “Clinical interpretation”When chronic migraine is included in the seed graph, the site can connect toxin biology, therapeutic evidence, manufacturer strategy, and patient-facing interest within a single topic cluster. The dose calculation overview page is a useful companion because patterned site distribution and repeat-session logic matter more here than simple brand shorthand. The safety and adverse-effect framing page helps readers separate migraine-specific weakness concerns from broader spread myths.